Close

Janssen (JNJ) Announces Rolling Submission of Daratumumab BLA to U.S. FDA

June 5, 2015 11:59 AM EDT Send to a Friend
Janssen Research & Development, LLC -- part of the Janssen Pharmaceutical Companies of -- has initiated the rolling submission of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login